Press Releases Year None20202019201820172015 May 27, 2020 ORIC Pharmaceuticals Announces Five Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II May 26, 2020 ORIC Pharmaceuticals to Present at the Jefferies 2020 Global Healthcare Conference May 20, 2020 ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results April 28, 2020 ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares April 27, 2020 ORIC Pharmaceuticals Presents Preclinical Data on CD73 Inhibitor at the American Association for Cancer Research (AACR) Virtual Annual Meeting April 23, 2020 ORIC Pharmaceuticals Announces Pricing of Initial Public Offering April 2, 2020 ORIC Pharmaceuticals Appoints Christian V. Kuhlen, M.D., as General Counsel March 2, 2020 ORIC Pharmaceuticals Appoints Mardi C. Dier to its Board of Directors January 27, 2020 ORIC Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial of ORIC-101 in Combination with XTANDI® for the Treatment of Prostate Cancer in Collaboration with Astellas January 2, 2020 ORIC Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference
